Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

NEK2

RBC: NEK2 · Substrate: MBP · medium confidenceReferenceDerived

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Neratinib91.10.60
Infigratinib51.00.71
Vemurafenib48.10.60
Gilteritinib47.40.51
Bosutinib46.10.55
Pazopanib42.60.67
Sunitinib22.00.52
Tivozanib17.20.67
Dabrafenib17.20.63
Ripretinib13.70.67
Fostamatinib13.30.61
Tofacitinib11.40.68
Dacomitinib11.30.66
Defactinib10.50.45
Ibrutinib10.30.72

Known variants

No variants catalogued.
Open in new tab